Debate: Endovascular Treatment is preferred for CLTI Patients with Infrapopliteal Disease

Monday, March 10, 2025

10:20 AM – 10:27 AM ET

Speaker(s)

Jun Li, MD

Co-Director, Heart and Vascular Institute and Co-Director, Pulmonary Embolism Response Team
University Hospitals Harrington Heart & Vascular Institute
Brecksville, Ohio, United States

Disclosure(s): Abbott Vascular,: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Disclosure(s):

Jun Li, MD: Abbott Vascular,: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Inari Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)